Cargando…

The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

BACKGROUND: Insulin resistance (IR) and type 2 diabetes have been found to increase the risk for Alzheimer’s clinical syndrome in epidemiologic studies but have not been associated with tau tangles in neuropathological research and have been inconsistently associated with cerebrospinal fluid P-tau18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ennis, Gilda E., Betthauser, Tobey J., Koscik, Rebecca Langhough, Chin, Nathaniel A., Christian, Bradley T., Asthana, Sanjay, Johnson, Sterling C., Bendlin, Barbara B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022314/ https://www.ncbi.nlm.nih.gov/pubmed/36932429 http://dx.doi.org/10.1186/s13195-023-01180-2

Ejemplares similares

Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer’s Disease
por: Mueller, Kimberly D., et al.
Publicado: (2022)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer’s Prevention
por: Du, Lianlian, et al.
Publicado: (2023)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)

Greater tau pathology is associated with altered predictive coding
por: Gjini, Klevest, et al.
Publicado: (2022)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

Trajectory of clinical symptoms in relation to amyloid chronicity
por: Birdsill, Alex C., et al.
Publicado: (2022)

Sex differences in off-target binding using tau positron emission tomography
por: Smith, Ruben, et al.
Publicado: (2021)

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
por: Ashton, Nicholas J., et al.
Publicado: (2022)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
por: Willette, Auriel A., et al.
Publicado: (2013)

Prescription Medications and Co-Morbidities in Late Middle-Age are Associated with Greater Cognitive Declines: Results from WRAP
por: Du, Lianlian, et al.
Publicado: (2022)

Measuring longitudinal cognition: Individual tests versus composites
por: Jonaitis, Erin M., et al.
Publicado: (2019)

In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease
por: Levin, Fedor, et al.
Publicado: (2021)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status
por: Gallagher, Rigina L., et al.
Publicado: (2023)

Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts
por: Betthauser, Tobey J, et al.
Publicado: (2022)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
por: Allison, Samantha L., et al.
Publicado: (2019)

Impact of cerebral blood flow and amyloid load on SUVR bias
por: Heeman, Fiona, et al.
Publicado: (2022)

Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention
por: Cody, Karly A., et al.
Publicado: (2022)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD
por: Schultz, Stephanie A., et al.
Publicado: (2015)

Positive affect predicts cerebral glucose metabolism in late middle-aged adults
por: Nicholas, Christopher R., et al.
Publicado: (2017)

Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
por: Bullich, Santiago, et al.
Publicado: (2017)

Time-varying SUVr reflects the dynamics of dopamine increases during methylphenidate challenges in humans
por: Tomasi, Dardo, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
por: Kim, Won Hwa, et al.
Publicado: (2018)

Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study
por: Heston, Margo B., et al.
Publicado: (2023)

Impact of sex and APOE ε4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study
por: Wang, Rui, et al.
Publicado: (2021)

Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer’s Prevention
por: Mueller, Kimberly D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ud18rnc4hlgk7oaq8s1knvl11o